"The Allegra 6 Series is designed for high-volume labs requiring a simple, durable solution above all else. Save time with the basic, streamlined user interface that is easy to use and quick to program. Available in refrigerated and ambient benchtop and refrigerated knee-well models."
Laboratory has four incubators.
With model 300 controller.
Lab owns 2 of these instruments.
Plasmid was derived from the eukaryotic expression vector pVR1020, provided by Vical, Inc. (San Diego, CA). This vector contains the cytomegalovirus (CMV) immediate early promoter, including the intron A, the bovine growth hormone polyadenylation signal, and the tissue plasminogen activator (tpa) leader sequence. The tpa leader sequence was not included in the final constructs.
Organism expression target: The recombinant prM/E proteins from Dengue virus can be expressed in eukaryotic cells. COS-7 and 293T cells were used to test the in vitro expression of these proteins.
Plasmid was derived from the eukaryotic expression vector pVR1020, provided by Vical, Inc. (San Diego, CA). This vector contains the cytomegalovirus (CMV) immediate early promoter, including the intron A, the bovine growth hormone polyadenylation signal, and the tissue plasminogen activator (tpa) leader sequence. The tpa leader sequence was not included in the final constructs.
Organism expression target: The recombinant prM/E proteins from Dengue virus can be expressed in eukaryotic cells. COS-7 and 293T cells were used to test the in vitro expression of these proteins.
Plasmid was derived from the eukaryotic expression vector pVR1020, provided by Vical, Inc. (San Diego, CA). This vector contains the cytomegalovirus (CMV) immediate early promoter, including the intron A, the bovine growth hormone polyadenylation signal, and the tissue plasminogen activator (tpa) leader sequence. The tpa leader sequence was not included in the final constructs.
Organism expression target: The recombinant prM/E proteins from Dengue virus can be expressed in eukaryotic cells. COS-7 and 293T cells were used to test the in vitro expression of these proteins.
Plasmid was derived from the eukaryotic expression vector pVR1020, provided by Vical, Inc. (San Diego, CA). This vector contains the cytomegalovirus (CMV) immediate early promoter, including the intron A, the bovine growth hormone polyadenylation signal, and the tissue plasminogen activator (tpa) leader sequence. The tpa leader sequence was not included in the final constructs.
Organism expression target: The recombinant prM/E proteins from Dengue virus can be expressed in eukaryotic cells. COS-7 and 293T cells were used to test the in vitro expression of these proteins.
Parental vector (VR1020) provided by Vical through MTA.